-
101
Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)
Published 2024-03-01Subjects: Get full text
Article -
102
Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
Published 2020-01-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
103
Clinical Course of Untreated and Treated Chronic Hepatitis B in Pregnant Patients: A Prospective Study
Published 2021-12-01Subjects: “…Chronic hepatitis B…”
Get full text
Article -
104
Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
Published 2020-09-01Subjects: “…hepatitis b…”
Get full text
Article -
105
Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
Published 2019-01-01Subjects: “…hepatitis c…”
Get full text
Article -
106
Evaluation of Small Intestinal Permeability in Patients with Overlap Syndrome (Autoimmune Hepatitis/Primary Biliary Cholangitis)
Published 2023-06-01Subjects: Get full text
Article -
107
Chronic glomerulonephritis of the mixed type in patient with HBV-infection (<i>Clinical case</i>)
Published 2013-07-01Subjects: “…hepatitis b…”
Get full text
Article -
108
Outcomes of the toxic hepatites caused by alcohol surrogates
Published 2013-12-01Subjects: “…toxic hepatitis…”
Get full text
Article -
109
Demographics, aetiology and outcome of paediatric acute liver failure in Singapore
Published 2022-11-01Subjects: “…hepatitis…”
Get full text
Article -
110
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
Published 2018-08-01“…Nowadays the question, whether pegylated interferon should be completely abandoned in the treatment of chronic hepatitis C (CHC) is still open. Beneficial interferon properties include: absence of mutagenic capacity for hepatitis C virus and drug interaction, stimulation of host immune response. …”
Get full text
Article -
111
-
112
Revealing viral hepatitis epidemiology in the Democratic Republic of Congo: insights from yellow fever surveillance reanalysis
Published 2025-02-01Subjects: “…Hepatitis…”
Get full text
Article -
113
The role of multifocal visual evoked potential in detection of minimal hepatic encephalopathy in patients with compensated liver cirrhosis
Published 2025-02-01Subjects: Get full text
Article -
114
Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
Published 2024-03-01Subjects: “…autoimmune hepatitis…”
Get full text
Article -
115
Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
Published 2025-02-01Subjects: Get full text
Article -
116
Extra-Hepatic Portal Venous Obstruction in Pregnant Women of South-Asian Descent: A Case Series
Published 2024-12-01“… Liver diseases complicate approximately 3% of pregnancies worldwide, and require specialized care to ensure optimal pregnancy outcomes. Extra-hepatic portal venous obstruction (EHPVO), even though asymptomatic in a majority of the cases, has a higher risk of variceal bleeding in pregnancy and adverse pregnancy outcomes. …”
Get full text
Article -
117
Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)
Published 2018-08-01“…Overall 164 patients with hepatitis C viruses (HCV) genotypes 1, 2 and 3 in 4 medical centers received antiviral therapy. …”
Get full text
Article -
118
Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
Published 2018-08-01“…To estimate the effect of carriage of endothelial dysfunction and hemostasis gene allelic variants on development of cryoglobulinemic vasculitis (CryoVas) and its clinical symptoms in patients with chronic hepatitis C (CHC). Material and methods. Original study included overall 72 patients with CHC and cryoglobulinemia: 21 patients had CryoVas, 51 - CHC without vasculitis. …”
Get full text
Article -
119
Development and characterization of a double-crested cormorant hepatic cell line, DCH22, for chemical screening
Published 2025-02-01“…In this study, an immortalized DCCO hepatic cell line, DCH22, was established from the liver of a day 22 female embryo as a potential alternative to primary DCCO embryonic hepatocytes (DCEH) for chemical screening. …”
Get full text
Article -
120
Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
Published 2013-06-01“…**Background:** Recent international, randomized, placebo-controlled clinical trials (SPRINT-2; RESPOND-2) demonstrated that the triple combination of peginterferon (PEG), ribavirin (RBV) and boceprevir (BOC) was more efficacious than the standard dual therapy of PEG and RBV in treatment of patients chronically infected with genotype 1 hepatitis C virus (HCV) infection. The objective of this study was to evaluate the cost-effectiveness of triple therapy in both treatment-naive and treatment-experienced patients in Hungary. …”
Get full text
Article